- 询价
- Nebulabio
- 中国
- NBAB-160196
- 2025年12月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
A synthetic peptide corresponding to the center region of the Human p-Tau181
- 形态：
liquid
- 克隆性：
单克隆
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 靶点：
p-Tau181
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名：NebuSelect™ Anti-Human p-Tau181 Monoclonal Antibody
别名：p-Tau181
货号：NBAB-160196
品牌：Nebulabio
规格：100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-Human p-Tau181 Monoclonal Antibody (CAT# NBAB-160196) was produced in rabbit immunized with a synthetic peptide corresponding to the center region of the Human p-Tau181, and it reacts with human. This antibody is validated for ELISA.
| 产品属性
Product Category：Rabbit MAb
Reactivity：Human
Specificity：p-Tau181
Immunogen：A synthetic peptide corresponding to the center region of the Human p-Tau181
Isotype：Monoclonal Rabbit IgG
Purification：Protein A & Antigen Affinity
Buffer：0.2 μm filtered solution in PBS, containing 1% BSA, 0.02% Proclin 300 and 50% Glycerol.
Conjugate：Unconjugated
Applications：ELISA
Dilution：ELISA 1:1000～1:8000
Storage：This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.For Research Use Only!
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Human Monoclonal Antibodies: The Residual Challenge of Antibody Immunogenicity
One of the major reasons for seeking human monoclonal antibodies has been to eliminate immunogenicity seen with rodent antibodies. Thus far, there has yet been no approach which absolutely abolishes that risk for cell-binding antibodies
Generation of a Monoclonal Antibody Library Against Human Embryonic Stem Cells
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases and to model early human embryonic development in vitro. Fulfilling this potential, however, requires extensive
Monoclonal Antibody-Based Strategies in Autoimmunity and Transplantation
of therapeutic monoclonal antibodies in the fields of transplantation and autoimmunity, and discuss the salient features of antibodies presently used in the clinic-notably anti-T-cell and anticytokine antibodies. The discussion will also focus on the unique
技术资料暂无技术资料 索取技术资料
